OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website
March 16, 2023 03:01 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye...
OKYO Pharma Limited Prices $5.3 Million Offering of ADSs
March 13, 2023 16:15 ET
|
OKYO Pharma LTD
LONDON, March 13, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel...
OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease
February 28, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye...
OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to Its Scientific Advisory Board
February 23, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease...
OKYO Pharma to Present at the Second Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on February 21-23, 2023.
February 21, 2023 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) (“OKYO”, “OKYO Pharma” or the “Company”), an ophthalmology-focused bio-pharmaceutical company...
Bruder Healthcare Now Exclusive Licensor of the Dry Eye Drink™ -- First and Only Ophthalmic Anti-Inflammatory Hyper-Hydrating Drink
February 13, 2023 10:00 ET
|
Bruder Healthcare
ATLANTA, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Bruder Healthcare, a Hilco Vision Company, announced an exclusive licensing agreement with Baton Rouge-based Dry Eye Drink LLC, the manufacturer of a...
Dry Eye Products Global Market Report 2022: Rising Incidence of Condition Bolsters Growth
January 10, 2023 10:26 ET
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Antibiotic Drops, Hormone Drops, Artificial Tears and...
Dry Eye Products Global Market Report 2022: Rising Incidence of Condition Bolsters Growth
January 10, 2023 10:24 ET
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Antibiotic Drops, Hormone Drops, Artificial Tears and...
Global Dry Eye Disease Market Report 2022: Increasing Emergence of Novel Treatments Presents Opportunities
December 20, 2022 08:33 ET
|
Research and Markets
Dublin, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease Market By product, By distribution channel & By region-Forecast Analysis 2022-2028" report has been added to ...
Ophthalmic Drugs Market to Develop at CAGR of 6.83% during Forecast Period: TMR Study
November 16, 2022 13:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - In 2021, the value of the ophthalmic drugs market stood at US$ 26.46 Bn. Analysis of...